Nurse Anesthetist - CR in Owings Mills, MD Accepting Medicare
5 Nurse Anesthetist - CR nurses found. Showing 1 - 5
 Novlet Marvalyn Fenwick, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 23 Crossroads Dr, Owings Mills, MD 21117 Phone: 410-356-0300 |
Laurie Bing Rogers, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 23 Crossroads Dr, Owings Mills, MD 21117 Phone: 410-356-0300 Fax: 410-356-0309 |
Virginia Marie Boyer, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 23 Crossroads Dr, Owings Mills, MD 21117 Phone: 410-356-0300 |
 Brian Salsberry, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 5 Millpaint Ln, Apt 1a, Owings Mills, MD 21117 Phone: 267-441-6510 |
Diane Krasna, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 25 Crossroads Dr, Owings Mills, MD 21117 Phone: 908-653-9399 |
News Archive
ER could be a good place to identify undiagnosed eating disorders among teens
Could the emergency room be a good place to spot undiagnosed eating disorders among teens, and help steer them to treatment? A new study from the University of Michigan suggests that could be the case.
Rheumatoid arthritis doubles a person's risk of heart attack
People coping with rheumatoid arthritis or lupus already have a lot to deal with. Even so, paying attention to heart health may be especially important for this group.
Sanofi enters definitive agreement to acquire Pluromed
Sanofi and Pluromed Inc. announced today that they have entered into a definitive agreement under which Sanofi is to acquire Pluromed Inc., a medical device company based in Woburn, Massachusetts.
Pluristem begins enrollment following FDA approval for clinical trials of its PLX-PAD stem cell product
Pluristem Therapeutics Inc. (NasdaqCM: PSTI) (DAX: PJT) today announced that it has begun enrolling patients in the U.S. for a Phase I clinical trial with its unmatched placenta-derived stem cell product, PLX-PAD, the Company's leading product candidate for the treatment of critical limb ischemia (CLI), the end-stage of peripheral artery disease (PAD).
Researchers reveal new pathway for inhibiting growth of tumor cells tied to BRCA mutations
Inhibiting the action of a particular enzyme dramatically slows the growth of tumor cells tied to BRCA1 and BRCA2 genetic mutations which, in turn, are closely tied to breast and ovarian cancers, according to researchers at NYU Langone Medical Center.
› Verified 4 days ago
Nurse Practitioner
Physician Assistant
Registered Nurse
Nurse Anesthetist - CR